로딩 중…
지수 로딩 중…
IVIM Technology
460470· KOSDAQ· Health Care· Health Care Equipment & Services
₩2,465+2.07%
2026-11-02
Financials
Valuation Metrics
IVIM Technology's Market Cap is ₩373B. At end of 2025 it was ₩497B. Ranked #1896 of 2,405 in KR market (top 79%), #1179 of 1,627 on KOSDAQ (top 72%), #80 of 94 in Health Care Equipment & Services (top 85%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 37.27B KRW | KR#1,896/2,405 Sec#80/94 |
| Revenue | 6.56B KRW | KR#2,303/2,405 Sec#82/94 |
| Net Income | -2.68B KRW | KR—/2,405 Sec—/94 |
| Total Assets | 28.72B KRW | KR#2,334/2,405 Sec#88/94 |
| Net Assets | 26.17B KRW | KR#2,206/2,405 Sec#80/94 |
| Employees | 37 | KR#2,140/2,405 Sec#83/94 |
| Value | ||
| P/B | 1.42x | KR#1,787/2,405 Sec#57/94 |
| P/S | 5.68x | KR#2,180/2,405 Sec#76/94 |
| FCF Yield | -17.98% | KR—/2,405 Sec—/94 |
| Profitability | ||
| ROE | -10.25% | KR#1,941/2,405 Sec#68/94 |
| ROA | -9.34% | KR#2,079/2,405 Sec#73/94 |
| Op. Margin | -47.27% | KR#2,215/2,405 Sec#77/94 |
| Revenue Growth | 22.77% | KR#501/2,405 Sec#26/94 |
| Financial Health | ||
| Debt Ratio | 9.75% | KR#132/2,405 Sec#8/94 |
| Total Debt | 791.3M KRW | KR#1,974/2,405 Sec#76/94 |
| FCF | -6.70B KRW | KR#1,571/2,405 Sec#53/94 |
| Cash | 4.60B KRW | KR#2,023/2,405 Sec#72/94 |
| Current Ratio | 18.66x | KR#30/2,405 Sec#3/94 |
| Performance | ||
| 1Y Return | -23.68% | KR#1,199/2,405 Sec#34/94 |
| 1M Return | -17.00% | KR#1,695/2,405 Sec#70/94 |
| From 52W High | -50.15% | KR#1,189/2,405 Sec#42/94 |
| 1Y MDD | -49.10% | KR#919/2,405 Sec#35/94 |
| Trading | ||
| Volume | 7,803 shares | KR#1,951/2,405 Sec#79/94 |
| Trading Value | 19.1M KRW | KR#2,106/2,405 Sec#84/94 |
| Foreign Own. | 1.28% | KR#1,913/2,405 Sec#68/94 |
| Per Share | ||
| EPS | -177 KRW | KR—/2,405 Sec—/94 |
| BPS | 1,731 KRW | KR#2,135/2,405 Sec#75/94 |
Company Info
IVIMTechnology Co., Ltd. specializes in pioneering solutions for the concurrent imaging of cells and bio-drugs within the diverse tissues and organs of living organisms. Its product line includes models like IVM-C3, IVM-M3, IVM-CM3, and IVM-MS3. The company was established on June 23, 2017, by co-founders Kim Pil-Han and Kim In-Sun, and is based in Daejeon, South Korea.